Testing effectiveness (Phase 2)Ended earlyNCT03362073
What this trial is testing
Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients
Who this might be right for
KetamineRefractory Cancer Pain
Pusan National University Yangsan Hospital 20